Health Care

4548 posts

Argent Biopharma executes global licence for non-core Cannabis genetics

Argent BioPharma has entered into a worldwide licensing agreement with TPI for the commercial development of…

LTR Pharma’s SPONTAN investigation in pulmonary arterial hypertension approved

LTR Pharma has received approval for an investigator-initiated clinical study evaluating SPONTAN in patients with newly…

Pro Medicus signs $43M, seven-year contract with Virtua Health in US

Pro Medicus' wholly-owned US subsidiary, Visage Imaging, has signed a seven-year, $43 million contract with Virtua…

Recce welcomes positive phase 3 clinical trial data for topical gel for diabetic foot ulcer infections

Recce Pharmaceuticals has reported a review of blinded data of its current phase 3 trial has…
Blood sample blood test blood concept

Newest ASX listee Identifai Genetics up +20% on IPO day eyeing prenatal screening disruption in the USA

The newest company to hit the ASX, Identifai Genetics (ASX:ID1), has seen its shares jump +20% on some...
Lung imaging concept

With the ASX in a better mood, 4D Medical climbs 7% back to $4.30/sh

4D Medical (ASX:4DX) appears to be back on investors’ radars on Monday as the stock climbed nearly +7% back
Human brain neurons

Cogstate jumps higher as 1Q27 sales hit US$25M; shares up +70% YTD

Digital cognitive assessment player Cogstate (ASX:CGS) has seen its shares jump nearly +12% higher in the intraday Monday session
Lung imaging concept

Racura greenlit to increase dose of RC220 for one patient in ongoing lung cancer combo treatment trial

Racura Oncology (ASX:RAC) has been greenlit by a safety committee to increase to 100mg the dose of its novel

Noxopharm receives US FDA feedback supporting SOF-SKN Phase II plans

Noxopharm has received constructive feedback from the US FDA for its planned Phase II clinical trial…
Nasal spray user

LTR Pharma jumps on first US sales of erectile dysfunction nasal spray ROXUS

LTR Pharma (ASX:LTP), best known for creating nasal-spray-based viagra alternatives, jumped +10% on Tuesday after fillings the first prescriptions